GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » FCF Yield %

Epi Biotech Co (XKRX:446440) FCF Yield % : 0.00 (As of Dec. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Epi Biotech Co's Trailing 12-Month Free Cash Flow is ₩0.00 Mil, and Market Cap is ₩35,381.56 Mil. Therefore, Epi Biotech Co's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Epi Biotech Co's FCF Yield % or its related term are showing as below:


XKRX:446440's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -12.65
* Ranked among companies with meaningful FCF Yield % only.

Epi Biotech Co's FCF Margin % for the quarter that ended in . 20 was 0.00%.


Epi Biotech Co FCF Yield % Historical Data

The historical data trend for Epi Biotech Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co FCF Yield % Chart

Epi Biotech Co Annual Data
Trend
FCF Yield %

Epi Biotech Co Semi-Annual Data
FCF Yield %

Competitive Comparison of Epi Biotech Co's FCF Yield %

For the Biotechnology subindustry, Epi Biotech Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epi Biotech Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Epi Biotech Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Epi Biotech Co's FCF Yield % falls into.



Epi Biotech Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Epi Biotech Co's FCF Yield % for the fiscal year that ended in . 20 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
= /
=N/A%

Epi Biotech Co's annualized FCF Yield % for the quarter that ended in . 20 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
= * 1 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epi Biotech Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Epi Biotech Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Epi Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines